| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 19,463 | 17,908 | 16,246 | | Cost of Revenue | 3,140 | 3,019 | 2,464 | | | Gross Profit | 16,323 | 14,889 | 13,782 | | | Operating Expenses | | Research Development | 3,894 | 3,710 | 3,809 | | Selling General and Administrative | 12,722 | 14,547 | 14,200 | | Non Recurring | 40 | 2,011 |
-
| | Others | 1,870 | 1,753 | 1,843 | | | | Total Operating Expenses | 18,526 | 22,021 |
-
| | | | Operating Income or Loss | (2,203) | (7,132) | (6,070) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37 | 142 | 144 | | Earnings Before Interest And Taxes | (2,166) | (6,990) | (5,926) | | Interest Expense | 493 | 373 |
-
| | Income Before Tax | (2,659) | (7,363) | (5,926) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,659) | (7,363) | (5,926) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,659) | (7,363) | (5,926) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,659) | ($7,363) | ($5,926) |
|
0.34% Nasdaq 
0.06 (4.11%) 
Income Statement
